Synthetic cannabinoid drug use as a cause or contributory cause of death

Forensic Science International : Synergy
Laura M LabayB K Logan

Abstract

Adverse effects associated with synthetic cannabinoid use include agitation, psychosis, seizures and cardiovascular effects, all which may result in a lethal outcome. We report the collection of data from 25 medical examiner and coroner cases where the presence of synthetic cannabinoids was analytically determined. Participating offices provided case history, investigative and relevant autopsy findings and toxicology results along with the cause and manner of death determination. This information, with the agency and cause and manner of death determinations blinded, was sent to participants. Participants offered their opinions regarding the likely contribution of the toxicology findings to cause and manner of death. The results show that some deaths are being attributed to synthetic cannabinoids, with the highest risk areas being behavioral toxicity resulting in excited delirium, trauma or accidents and as contributing factors in subjects with pre-existing cardiopulmonary disease. While insufficient information exists to correlate blood synthetic cannabinoid concentrations to effect, in the absence of other reasonable causes, the drugs should be considered as a cause or contributory cause of death based on history and circumsta...Continue Reading

References

May 12, 2012·Annals of Emergency Medicine·Christopher O HoyteKennon J Heard
Aug 24, 2013·Journal of Analytical Toxicology·Robert KronstrandArne Eklund
Oct 31, 2013·The International Journal of Neuropsychopharmacology·Jolanta B Zawilska, Jakub Wojcieszak
May 31, 2014·Journal of Analytical Toxicology·George BehonickChady Meroueh
Aug 5, 2014·Journal of Forensic Sciences·Nikolas P Lemos

❮ Previous
Next ❯

Citations

Dec 2, 2017·Journal of Forensic Sciences·Anthea B Mahesan PaulAbraham Ebenezer Paul
Nov 21, 2018·Substance Abuse : Official Publication of the Association for Medical Education and Research in Substance Abuse·Kirsten Elin Smith, Michele Staton
Sep 15, 2017·Nature Reviews. Cardiology·Pal PacherGeorge Kunos
Aug 8, 2019·Clinical Toxicology : the Official Journal of the American Academy of Clinical Toxicology and European Association of Poisons Centres and Clinical Toxicologists·Shane DarkeJulia Lappin
Jul 12, 2017·Behavioural Pharmacology·Nicholas PintoriMaddalena Mereu
Feb 27, 2020·Pharmacology Research & Perspectives·Shivani SachdevMark Connor
Aug 23, 2020·Forensic Science, Medicine, and Pathology·Ellen M F StrömmerMichael D Freeman
May 2, 2017·Journal of Analytical Toxicology·Barry K LoganMarilyn A Huestis
Jun 12, 2020·Frontiers in Psychiatry·Arianna GiorgettiRaffaele Giorgetti
Jul 4, 2020·Clinical Toxicology : the Official Journal of the American Academy of Clinical Toxicology and European Association of Poisons Centres and Clinical Toxicologists·Piotr Adamowicz
Apr 7, 2020·Archives of Toxicology·Dino Luethi, Matthias E Liechti
May 10, 2019·Medicine, Science, and the Law·Phoebe SharpStephen R Morley
Feb 3, 2019·Pediatrics in Review·George Sam Wang, Christopher Hoyte
Aug 4, 2020·EClinicalMedicine·Paul L MorrowRichard Massey
Aug 4, 2021·The International Journal on Drug Policy·Shane DarkeJulia Lappin
Dec 19, 2021·International Journal of Legal Medicine·Franziska Gaunitz, Hilke Andresen-Streichert

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Related Papers

The American Journal of Forensic Medicine and Pathology
J H Davis
JAMA : the Journal of the American Medical Association
J Plunkett, L C Thomas
JAMA : the Journal of the American Medical Association
E J Neiburger
© 2022 Meta ULC. All rights reserved